Aastrom Biosciences Inc., of Ann Arbor, Mich., formed its technology review board, consisting of Michael Ehrenreich, Armand Keating, Gunnar Kvalheim, James Mulé and Susan Wyant.

Advanced Viral Research Corp., of Yonkers, N.Y., added Mark Kaplan to its scientific advisory board.

Amgen Inc., of Thousand Oaks, Calif., added Hassan Dayem as senior vice president and chief information officer.

Archemix Corp., of Cambridge, Mass., appointed Steven Holtzman to its board.

Array BioPharma Inc., of Boulder, Colo., appointed James Winkler director of discovery biology.

Arrow Therapeutics Ltd., of London, added David Chiswell to its board as deputy chairman.

Astex Technology Ltd., of Cambridge, UK, appointed Neil Thompson vice president of biology.

AVI BioPharma Inc., of Portland, Ore., appointed Andrew Ferrara to its board.

Biogen Inc., of Cambridge, Mass., appointed Michael Kowolenko vice president, global quality.

British Biotech plc, of Oxford, UK, promoted Tim Edwards to chief operating officer.

Connetics Corp., of Palo Alto, Calif., appointed Charles Democko vice president, regulatory affairs.

Epoch Biosciences Inc., of Bothell, Wash., appointed Cy Cabradilla vice president, operations.

Flagship Ventures, of Cambridge, Mass., added James Serum as a venture partner.

Genentech Inc., of South San Francisco, promoted Hal Barron to vice president, medical affairs.

Genitope Corp., of Redwood City, Calif., added Bonnie Charpentier as vice president of regulatory affairs and Tom DeZao as vice president of strategic marketing and sales. Also, Fred Kurland was named vice president and chief financial officer and Laurie Torres named vice president of human resources.

Illumina Inc., of San Diego, promoted John Stuelpnagel to senior vice president of operations.

Immune Network Ltd., of Vancouver, British Columbia, appointed Hugh Wynne-Edwards to its board.

Kiadis BV, of Leiden, the Netherlands, appointed Steve Long director, drug discovery.

Neose Technologies Inc., of Horsham, Pa., appointed Elizabeth Wyatt to its board.

NicOx SA, of Sophia Antipolis, France, appointed Sylvain Goyon director of corporate relations.

Organogenesis Inc., of Canton, Mass., named Gary Gillheeney vice president of corporate development, chief financial officer and treasurer.

PPD Inc., of Wilmington, N.C., appointed Linda Baddour chief financial officer.

Versant Ventures, of Menlo Park, Calif., added Kevin Wasserstein as an associate.

Vion Pharmaceuticals Inc., of New Haven, Conn., appointed Louis Weiner to its scientific advisory board.

Xenon Genetics Inc., of Vancouver, British Columbia, appointed Rajender Kamboj vice president, drug discovery.

No Comments